MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics ROE Ratio 2011-2026 | SLNO
Annual ROE Ratio Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -71.74 | -24.75 | -232.58 | -173.72 | -54.1 | -205.89 | -43.85 | -59.04 | -351.22 | -493.47 | 134.28 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 134.28 | -493.47 | -143.28 |
Quarterly ROE Ratio Soleno Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -44.49 | -78.7 | -84.52 | -51.65 | -98.43 | -116.26 | -176.68 | -431.61 | -471.96 | -465.52 | -430.43 | -95.09 | -135.38 | -135.33 | -142.26 | -104.17 | -122.93 | -101.4 | -77.57 | -47.83 | -41.89 | -17.18 | -67.92 | -108.04 | -117.04 | -131.98 | -88.23 | -44.71 | -58.83 | -63.95 | -55.7 | -39.96 | -120.01 | -185.95 | -273.27 | -275.17 | -377.34 | -399.45 | -238.82 | -405.31 | -287.0 | -66.53 | -6.59 | 354.91 | 359.11 | 245.0 | 126.7 | 4.2 | 4.2 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 359.11 | -471.96 | -118.14 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 3.1 | 2.31 % | $ 101 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 24.05 | -2.67 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.16 | -0.89 % | $ 1.09 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 33.54 | -5.15 % | $ 361 M |  China |
 |
Danaher Corporation
DHR
|
7.87 | $ 219.62 | -2.19 % | $ 161 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.3 | 0.05 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.24 | -0.61 % | $ 793 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.47 | -2.65 % | $ 1.87 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 110.48 | 0.68 % | $ 13.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.68 | 0.56 % | $ 4.61 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
26.18 | $ 74.0 | 0.87 % | $ 28.6 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.8 | 1.66 % | $ 1.12 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 12.4 | 0.16 % | $ 1.57 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 112.12 | -2.1 % | $ 4.42 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.3 | -6.02 % | $ 292 M | Israel |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Precipio
PRPO
|
-40.56 | $ 24.26 | -1.98 % | $ 31.5 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 9.97 | -0.2 % | $ 591 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 149.69 | -0.11 % | $ 23.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
22.63 | $ 235.62 | -1.73 % | $ 42.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.78 | $ 592.16 | -2.61 % | $ 226 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.87 | -4.13 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 211.68 | -2.4 % | $ 10.9 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 41.58 | -1.02 % | $ 2.49 B | USA |
 |
Medpace Holdings
MEDP
|
48.98 | $ 593.07 | -0.81 % | $ 18.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 182.35 | -0.21 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 9.66 | -6.49 % | $ 1.25 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 269.81 | 0.66 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 392.8 | -0.63 % | $ 29.6 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 185.89 | -0.23 % | $ 15.3 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 676.71 | -1.6 % | $ 55.8 B | USA |